New therapeutic agents in diabetic nephropathy
Yaeni Kim, Cheol Whee Park
Korean J Intern Med. 2017;32(1):11-25.   Published online 2017 Jan 1     DOI: https://doi.org/10.3904/kjim.2016.174
Citations to this article as recorded by Crossref logo
Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy
Zubair Ilyas, Joumana T. Chaiban, Armand Krikorian
Reviews in Endocrine and Metabolic Disorders.2017; 18(1): 21.     CrossRef
Comment on “New therapeutic agents in diabetic nephropathy”
Alain Gay, Peter Kolkhof
The Korean Journal of Internal Medicine.2017; 32(3): 569.     CrossRef
Brazilin Ameliorates Diabetic Nephropathy and Inflammation in db/db Mice
Zhan-yuan Li, Yu Zheng, Yan Chen, Min Pan, Shu-bei Zheng, Wen Huang, Zhi-hong Zhou, Han-yang Ye
Inflammation.2017; 40(4): 1365.     CrossRef
Response to comment on “New therapeutic agents in diabetic nephropathy”
Yaeni Kim, Cheol Whee Park
The Korean Journal of Internal Medicine.2017; 32(3): 570.     CrossRef
Treatment of diabetic kidney disease: current and future targets
Mi-Kyung Kim
The Korean Journal of Internal Medicine.2017; 32(4): 622.     CrossRef